HIV and OUD Service and Funding Matrices Guide and Template
Resource updated 04/18/2024
Resource updated 04/18/2024
Resource updated 06/05/2024
From the HRSA HIV/AIDS Bureau Listserv, 12/16/22
Resource (Conference Presentation) updated 09/14/2023
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
We used a data-driven, mixed method approach to develop a community planning and budget tool to inform resource allocation decision-making to achieve health equity in HIV outcomes among RWHAP clients in the Minneapolis-St. Paul Transitional Grant Area.
Resource (Conference Presentation) updated 09/14/2023
This presentation will share innovative strategies in the creation of a reflective Consumer Advisory Board, HIT HIV. The presentation will showcase quality improvement projects the HIT HIV CAB completed while leveraging technology, social media, consumer feedback, and CQM principles ensuring a community-driven and equitable process toward ending the HIV epidemic.
Resource (Conference Presentation) updated 09/14/2023
Review of data on delivery of rapid start of ART among New Jersey providers, including, for example, provision of same-day medical appointments, extended office hours, and comfort administering rapid start with high need patients.
Resource (Conference Presentation) updated 12/11/2023
Resource from the RWHAP Best Practices Compilation updated on 01/07/2024
Review of rapid ART features to reduce time to ART from 7 to 1.6 days, including pre-visit benefits navigation, manufacturer discount cards, prescribing to in-house pharmacies, email distribution lists, and post-prescriptive follow-up.
Resource (Conference Presentation) updated 09/14/2023
Virginia quality improvement program that identifies access to medication barriers and provides emergency medication supplies to people with HIV if no timely access is secured.
Resource (Conference Presentation) updated 09/14/2023
Harris Health System began its Rapid Eligibility and ART Dissemination & Implementation (READI) program in 2019. Here, we present two years of data that examine linkage to care, ART initiation, viral loads, completion of medical visits, and demographics for patients who received READI services and those who did not.
Resource (Conference Presentation) updated 09/14/2023
ELEVATE approaches to build the capacity of people with HIV to be meaningfully involved in planning, delivering, and improving RWHAP services.
Resource (Conference Presentation) updated 09/14/2023
Panel from the RWHAP community on community engagement and their stories.
Resource (Conference Presentation) updated 09/14/2023
Review of the RWHAP SPNS initiative Improving Care and Treatment Coordination for Black Women with HIV, which promotes meaningful involvement of Black women with HIV.
Resource (Conference Presentation) updated 09/14/2023
Introduction to HRSA HAB's Community Engagement Framework, update on community engagement activities across HAB and resources available to support community engagement.
Resource (Conference Presentation) updated 09/14/2023
Ryan White's story, as told by his mother, Jeanne White-Ginder. Hear about Ryan's personal struggles, his ability to rise above those barriers, and how he became a national spokesperson - forever changing the public's perception of AIDS.
Resource (Conference Presentation) updated 09/14/2023
Live with HAB Leadership: Mahyar Mofidi, DMD, PhD.
Resource (Conference Presentation) updated 09/14/2023